scholarly journals Final Result of Randomized Phase 2 Trial Comparing Amrubicin (A) with Re-Challenge of Platinum Doublet (P) in Patients (Pts) with Sensitive-Relapsed Small-Cell Lung Cancer (Sclc): Njlcg0702

2014 ◽  
Vol 25 ◽  
pp. iv514 ◽  
Author(s):  
M. Maemondo ◽  
A. Inoue ◽  
S. Sugawara ◽  
Y. Mori ◽  
S. Oizumi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Trial ◽  
Randomized Phase 2 ◽  
Platinum Doublet

scholarly journals Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer

Cancer ◽  
2015 ◽  
Vol 121 (18) ◽  
pp. 3298-3306 ◽  
Author(s):  
Karen L. Reckamp ◽  
Marianna Koczywas ◽  
Mihaela C. Cristea ◽  
Jonathan E. Dowell ◽  
He-Jing Wang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
High Dose ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Trial ◽  
Randomized Phase 2

scholarly journals Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial

2016 ◽  
Vol 24 (8) ◽  
pp. 3495-3505 ◽  
Author(s):  
Koichi Takayama ◽  
Nobuyuki Katakami ◽  
Takuma Yokoyama ◽  
Shinji Atagi ◽  
Kozo Yoshimori ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Japanese Patients ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Trial ◽  
Randomized Phase 2
Sign in / Sign up

Export Citation Format

Share Document